|

Chimeric antigen receptor T cells Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Also known as: CAR T Cell, CAR T Cells, CAR T-cells, CAR-T, CAR-T Cell +3 more

Pipeline

Phase 1: 1

Top Sponsors

  • City of Hope Medical Center1

Indications

  • Platinum-Resistant Ovarian Carcinoma1
  • Cancer1

Duarte, California1 trial

Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer

City of Hope Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.